A new study published in Science Translational Medicine reveals why EGFR inhibitors, which are approved to treat cancers such as lung and colorectal cancer, cause severe skin side effects.
We use cookies to help our site work, to understand how it is used, and to tailor the adverts presented on our site. By clicking “Accept” below, you agree to us doing so.OkRead more
